• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

额颞叶痴呆、阿尔茨海默病和帕金森病中的共享及疾病特异性通路。

Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.

作者信息

Ali Muhammad, Erabadda Buddhiprabha, Chen Yike, Xu Ying, Gong Katherine, Liu Menghan, Pichet Binette Alexa, Timsina Jigyasha, Western Daniel, Yang Chengran, Heo Gyujin, Vogel Jacob W, Tijms Betty M, Krish Varsha, Imam Farhad, Hansson Oskar, Winchester Laura, Cruchaga Carlos

机构信息

Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.

NeuroGenomics and Informatics Center, Washington University School of Medicine, St. Louis, MO, USA.

出版信息

Nat Med. 2025 Jul 15. doi: 10.1038/s41591-025-03833-1.

DOI:10.1038/s41591-025-03833-1
PMID:40665052
Abstract

Neurodegenerative diseases (NDs), such as Alzheimer's disease (AD), Parkinson's disease (PD) and frontotemporal dementia (FTD), exhibit distinct yet overlapping pathological mechanisms. Leveraging large-scale plasma proteomics data from the Global Neurodegeneration Proteomics Consortium, we analyzed 10,527 plasma samples (1,936 AD, 525 PD, 163 FTD, 1,638 dementia and 6,265 controls) to identify disease-specific and shared proteins across NDs. We identified 5,187 proteins significantly associated with AD, 3,748 with PD and 2,380 with FTD that revealed both common and divergent proteomic signatures, which were confirmed by multiple analytical approaches and orthogonal validation. PD and FTD showed the highest overlap (r = 0.44) and AD and PD the least (r = 0.04). Immune system, glycolysis, and matrisome-related pathways were enriched across all NDs, while disease-specific pathways included apoptotic processes in AD, endoplasmic reticulum-phagosome impairment in PD and platelet dysregulation in FTD. Network analysis identified key upstream regulators (RPS27A in AD, IRAK4 in PD and MAPK1 in FTD) potentially driving these proteomic changes. These findings reveal distinct and shared mechanisms across NDs, highlighting potential regulatory proteins and pathways for diagnostic and therapeutic strategies in neurodegeneration.

摘要

神经退行性疾病(NDs),如阿尔茨海默病(AD)、帕金森病(PD)和额颞叶痴呆(FTD),表现出不同但又相互重叠的病理机制。利用全球神经退行性疾病蛋白质组学联盟的大规模血浆蛋白质组学数据,我们分析了10527份血浆样本(1936份AD、525份PD、163份FTD、1638份痴呆症样本和6265份对照样本),以确定NDs中疾病特异性和共享的蛋白质。我们鉴定出5187种与AD显著相关的蛋白质、3748种与PD显著相关的蛋白质和2380种与FTD显著相关的蛋白质,这些蛋白质揭示了共同和不同的蛋白质组学特征,这通过多种分析方法和正交验证得到了证实。PD和FTD的重叠度最高(r = 0.44),AD和PD的重叠度最低(r = 0.04)。免疫系统、糖酵解和基质相关途径在所有NDs中均富集,而疾病特异性途径包括AD中的凋亡过程、PD中的内质网-吞噬体损伤和FTD中的血小板失调。网络分析确定了可能驱动这些蛋白质组学变化的关键上游调节因子(AD中的RPS27A、PD中的IRAK4和FTD中的MAPK1)。这些发现揭示了NDs中不同和共享的机制,突出了神经退行性疾病诊断和治疗策略中潜在的调节蛋白和途径。

相似文献

1
Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.额颞叶痴呆、阿尔茨海默病和帕金森病中的共享及疾病特异性通路。
Nat Med. 2025 Jul 15. doi: 10.1038/s41591-025-03833-1.
2
APOE ε4 carriers share immune-related proteomic changes across neurodegenerative diseases.载脂蛋白E4(APOE ε4)携带者在多种神经退行性疾病中存在与免疫相关的蛋白质组学变化。
Nat Med. 2025 Jul 15. doi: 10.1038/s41591-025-03835-z.
3
The role of blood-based biomarkers in Parkinsonian disorders, Alzheimer's disease and frontotemporal dementia.血液生物标志物在帕金森病、阿尔茨海默病和额颞叶痴呆中的作用。
J Neurol Sci. 2025 Sep 15;476:123617. doi: 10.1016/j.jns.2025.123617. Epub 2025 Jul 11.
4
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed dementia cohort.高灵敏度血浆蛋白质组学揭示了大型混合性痴呆队列中阿尔茨海默病表型的疾病特异性特征和预测性生物标志物。
Res Sq. 2025 Jun 29:rs.3.rs-6440485. doi: 10.21203/rs.3.rs-6440485/v1.
5
Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patterns.阿尔茨海默病、帕金森病和路易体痴呆中的自身抗体谱:在疾病特异性病理模式下,针对α-突触核蛋白、淀粉样β蛋白和tau蛋白的IgG亲和力改变以及IgG/IgM/IgA反应
J Neuroinflammation. 2024 Dec 3;21(1):317. doi: 10.1186/s12974-024-03293-3.
6
Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer's disease.路易体痴呆症大脑的网络蛋白质组学研究揭示了与阿尔茨海默病不同的突触前特征。
Mol Neurodegener. 2024 Aug 6;19(1):60. doi: 10.1186/s13024-024-00749-1.
7
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.全球神经退行性疾病蛋白质组学联盟:常见神经退行性疾病和衰老的生物标志物及药物靶点发现
Nat Med. 2025 Jul 15. doi: 10.1038/s41591-025-03834-0.
8
Changes of brain functional network in Alzheimer's disease and frontotemporal dementia: a graph-theoretic analysis.阿尔茨海默病和额颞叶痴呆的脑功能网络变化:图论分析。
BMC Neurosci. 2024 Jul 4;25(1):30. doi: 10.1186/s12868-024-00877-w.
9
Healthcare Service Utilisation of People Living With Non-Alzheimer's Dementia: A Systematic Review.非阿尔茨海默病性痴呆患者的医疗服务利用:一项系统综述。
J Geriatr Psychiatry Neurol. 2025 Aug 28:8919887251371725. doi: 10.1177/08919887251371725.
10
Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.用于检测疑似痴呆患者额颞叶痴呆的局部脑血流单光子发射计算机断层扫描
Cochrane Database Syst Rev. 2015 Jun 23;2015(6):CD010896. doi: 10.1002/14651858.CD010896.pub2.

引用本文的文献

1
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.全球神经退行性疾病蛋白质组学联盟:常见神经退行性疾病和衰老的生物标志物及药物靶点发现
Nat Med. 2025 Jul 15. doi: 10.1038/s41591-025-03834-0.

本文引用的文献

1
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.全球神经退行性疾病蛋白质组学联盟:常见神经退行性疾病和衰老的生物标志物及药物靶点发现
Nat Med. 2025 Jul 15. doi: 10.1038/s41591-025-03834-0.
2
Large-scale plasma proteomic profiling unveils diagnostic biomarkers and pathways for Alzheimer's disease.大规模血浆蛋白质组学分析揭示了阿尔茨海默病的诊断生物标志物和相关通路。
Nat Aging. 2025 May 20. doi: 10.1038/s43587-025-00872-8.
3
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.
脑脊液蛋白质组的大规模网络分析确定了额颞叶痴呆的分子特征。
Nat Aging. 2025 May 16. doi: 10.1038/s43587-025-00878-2.
4
PTEN: a new dawn in Parkinson's disease treatment.PTEN:帕金森病治疗的新曙光。
Front Cell Neurosci. 2025 Mar 10;19:1497555. doi: 10.3389/fncel.2025.1497555. eCollection 2025.
5
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum.多队列脑脊液蛋白质组学确定了阿尔茨海默病连续体中的强大分子特征。
Neuron. 2025 May 7;113(9):1363-1379.e9. doi: 10.1016/j.neuron.2025.02.014. Epub 2025 Mar 14.
6
Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia.血浆SMOC1和可溶性IL6RA水平与轻度认知障碍向痴呆进展的关联。
Brain Behav Immun Health. 2024 Nov 16;42:100899. doi: 10.1016/j.bbih.2024.100899. eCollection 2024 Dec.
7
SMOC1 colocalizes with Alzheimer's disease neuropathology and delays Aβ aggregation.SMOC1 与阿尔茨海默病神经病理学共存,并延缓 Aβ 聚集。
Acta Neuropathol. 2024 Nov 25;148(1):72. doi: 10.1007/s00401-024-02819-6.
8
Benchmarking of a multi-biomarker low-volume panel for Alzheimer's disease and related dementia research.用于阿尔茨海默病及相关痴呆症研究的多生物标志物低样本量检测板的基准测试。
Alzheimers Dement. 2025 Feb;21(2):e14413. doi: 10.1002/alz.14413. Epub 2024 Nov 22.
9
GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia.GWAS 分析多个神经病理学表型,确定新的风险位点,并深入了解痴呆症的遗传风险。
Nat Genet. 2024 Nov;56(11):2407-2421. doi: 10.1038/s41588-024-01939-9. Epub 2024 Oct 8.
10
Tau accumulation is cleared by the induced expression of VCP via autophagy.通过自噬诱导 VCP 的表达来清除 Tau 积累。
Acta Neuropathol. 2024 Sep 24;148(1):46. doi: 10.1007/s00401-024-02804-z.